<DOC>
	<DOCNO>NCT00048009</DOCNO>
	<brief_summary>The purpose study determine appropriate dose Ro 27-2441 ( test drug ) use future study , assess efficacy safety , anti-inflammatory action test drug treatment asthmatic patient currently receive chronic therapy corticosteroid . The research conduct 80 clinical research sit US , Mexico , Canada . Study participant number visit research site approximately 4-month period .</brief_summary>
	<brief_title>Evaluation Various Doses Ro 27-2771 ( Test Drug ) Asthmatic Patients Not Treated With Inhaled Corticosteroids</brief_title>
	<detailed_description />
	<criteria>Persistent asthma one year Current treatment asthma short act inhaled beta 2 agonist ( albuterol ) In good health ad demonstrate medical history physical exam Negative urine pregnancy test Commitment use two form effective contraception simultaneously throughout study duration one month discontinue therapy Asthma necessitate treatment inhaled corticosteroid least one month start study History severe asthma necessitating use oral/injectable corticosteroid within last 2 month and/and two burst last year Undergoing allergy shot unless stable maintenance dose three month start study History chronic pulmonary disease asthma Treatment condition asthma oral corticosteroid within one month start study Current tobacco use Smoking history great 10 packyear history cigarette smoking ( number pack smoke per day time number year smoke ) History evidence drug alcohol abuse Diagnosis evidence infectious illness within one month Visit 1 Clinically significant disease assess study doctor Participation another clinical study experimental drug within one month start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>